Thunder Biotech thunderbiotech.com


Thunder Biotech has an exclusive license to a patented technology developed at Brigham Young University that can detect cancer at a very early stage, which can then be used to eradicate that cancer using the body's innate immune system.

Thunder Biotech has an exclusive license to a patented technology developed at Brigham Young University that can detect cancer at a very early stage, which can then be used to eradicate that cancer using the body's innate immune system.

Company (Alive / Active)

All investors data 1 Investors

Phone: 801-382-7940

Fax:

730 East 100 North

 Alpine, 84004
 Utah, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Thunder Biotech $1.1M Nov 6, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Thunder Biotech Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Transgenic macrophages, chimeric antigen receptors, and associated methods Sep 16, 2019 Jan 12, 2021 Patent
Transgenic macrophages, chimeric antigen receptors, and associated methods May 17, 2017 Sep 17, 2019 Patent
Modified macrophages and macrophage precursors and associated methods Dec 13, 2018 Application